Literature DB >> 28017449

Anabolic resistance does not explain sarcopenia in patients with type 2 diabetes mellitus, compared with healthy controls, despite reduced mTOR pathway activity.

Daniel J Cuthbertson1, John Babraj2, Graham Leese3, Mario Siervo4.   

Abstract

BACKGROUND: Ageing and type 2 diabetes mellitus (T2DM) are risk factors for skeletal muscle loss. We investigated whether anabolic resistance to feeding might underlie accelerated muscle loss in older people with T2DM and whether dysregulated mTOR signalling was implicated.
SUBJECTS: 8 obese men with T2DM, and 12 age-matched controls were studied (age 68 ± 3 vs. 68±6 y; BMI: 30 ± 2 vs. 27 ± 5 kg m-2).
METHODS: Body composition was measured by dual-X-ray absorptiometry. Insulin and glucose were clamped at post-absorptive concentrations (13 ± 2 vs. 9 ± 3 mU l-1; 7.4 ± 1.9 vs. 4.6 ± 0.4 mmol l-1; T2DM vs. controls). Fractional synthetic rates (FSR) of myofibrillar and sarcoplasmic proteins were measured as the rate of incorporation of [13C] leucine during a primed, constant infusion of [1-13C] α-ketoisocaproic acid, 3 h after 10 or 20 g of essential amino acids (EAA) were orally administered. Protein expression of total and phosphorylated mTOR signalling proteins was determined by Western blot analysis.
RESULTS: Despite a significantly lower appendicular lean mass index and a greater fat mass index in T2DM vs. controls, basal myofibrillar and sarcoplasmic and post-prandial myofibrillar FSR were similar. After 20 g EAA, stimulation of sarcoplasmic FSR was slightly blunted in T2DM patients. Furthermore, feeding 20 g EAA increased phosphorylation of mTOR, p70S6k and 4E-BP1 by 60-100% in controls with no response observed in T2DM.
CONCLUSIONS: There was clear dissociation between changes in mTOR signalling versus changes in protein synthesis rates. However, the intact anabolic response of myofibrillar FSR to feeding in both groups suggests anabolic resistance may not explain accelerated muscle loss in T2DM.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Keywords:  Anabolic resistance; Insulin resistance; Obesity; Protein synthesis; Sarcopenia; Skeletal muscle

Mesh:

Substances:

Year:  2016        PMID: 28017449     DOI: 10.1016/j.clnu.2016.11.012

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  6 in total

1.  International society of sports nutrition position stand: tactical athlete nutrition.

Authors:  Drew E Gonzalez; Matthew J McAllister; Hunter S Waldman; Arny A Ferrando; Jill Joyce; Nicholas D Barringer; J Jay Dawes; Adam J Kieffer; Travis Harvey; Chad M Kerksick; Jeffrey R Stout; Tim N Ziegenfuss; Annette Zapp; Jamie L Tartar; Jeffery L Heileson; Trisha A VanDusseldorp; Douglas S Kalman; Bill I Campbell; Jose Antonio; Richard B Kreider
Journal:  J Int Soc Sports Nutr       Date:  2022-06-23       Impact factor: 4.948

2.  Age-Related Anabolic Resistance of Myofibrillar Protein Synthesis Is Exacerbated in Obese Inactive Individuals.

Authors:  Benoit Smeuninx; James Mckendry; Daisy Wilson; Una Martin; Leigh Breen
Journal:  J Clin Endocrinol Metab       Date:  2017-09-01       Impact factor: 5.958

3.  Circulating Irisin Levels as a Marker of Osteosarcopenic-Obesity in Cushing's Disease.

Authors:  Valentina Guarnotta; Antonio Prinzi; Maria Pitrone; Giuseppe Pizzolanti; Carla Giordano
Journal:  Diabetes Metab Syndr Obes       Date:  2020-05-11       Impact factor: 3.168

4.  The relationship of dietary total antioxidant capacity with sarcopenia and cardiometabolic biomarkers in type 2 diabetes patients.

Authors:  Nadya Baharirad; Yahya Pasdar; Mostafa Nachvak; Saeid Ghavamzadeh; Ali Soroush; Amir Saber; Shayan Mostafai; Armin Naghipour; Hadi Abdollahzad
Journal:  Physiol Rep       Date:  2022-02

5.  Alteration in the mRNA expression profile of the autophagy-related mTOR pathway in schizophrenia patients treated with olanzapine.

Authors:  Fengwei Cui; Shuguang Gu; Yue Gu; Jiajun Yin; Chunxia Fang; Liang Liu
Journal:  BMC Psychiatry       Date:  2021-08-04       Impact factor: 3.630

6.  Blood lipid profile changes in type 2 diabetic rats after tail suspension and reloading.

Authors:  Shoji Tanaka; Sachiko Madokoro; Pleiades Tiharu Inaoka; Toshiaki Yamazaki
Journal:  Lipids Health Dis       Date:  2021-08-01       Impact factor: 3.876

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.